World Cancer Day: How Far We’ve Come
For the past two decades, people around the globe have bound together to promote cancer awareness every February 4th, World Cancer Day. The Asian Fund for Cancer Research is honored to be one of over…
This past fall saw considerable progress in the development of GBM AGILE, the brain cancer clinical trial initiative whose early-stage planning has long been supported by the Asian Fund for Cancer Research. Not only was an acting head hired to run the…
The Asian Fund for Cancer Research remembers and recognizes the contributions of our esteemed scientific advisory board member, Waun Ki Hong, M.D., F.A.C.P., D.M.Sc. (Hon.), who passed away on 2 January, 2019, at the age of 76.
Born in 1942 in what is…
The Asian Fund for Cancer Research was proud to have been among the 50-plus organizations and companies to have participated in the Hong Kong Anti-Cancer Society’s Hong Kong Cancer Day activities, held Sunday, 2018-12-9, at the Piazza of Kowloon Park in Tsim…
On 2018-12-09, the Asian Fund for Cancer Research will be supporting and participating in the Hong Kong Anti-Cancer Society’s full day of Hong Kong Cancer Day programming. Actress Sonija Kwok will be serving as event ambassador, and among the special guests will…
Wang Jiguang (left), assistant professor at the division of life science, department of chemical and biological engineering, HKUST, and Professor Jiang Tao (right) from Beijing Tiantan Hospital, showing results of the clinical trial. Photo: Hong Kong University of Science and Technology
Researchers…
The 2018 USCACA-AFCR Scholar Award Ceremony in Tianjin on November 17, 2018
The Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly awarded six outstanding Chinese cancer researchers in the early stage of their careers with the 2018 USCACA-AFCR…
The United States Chinese Anti-Cancer Association and AFCR are pleased to invite nominations for the USCACA-AFCR 2018 Scholar Awards.
The Awards will recognize 4 to 5 junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research.
Candidacy is open to…
With lung cancer continuing to affect the lives of so many people, it’s important to understand the disease and what we can do to improve our chances of beating it.
1. Targeted therapies are showing great promise in treating lung cancer.
If you’ve been…
(clockwise) AFCR Founder and CEO Dr. Sujuan Ba, ECI Founder Mr. Andrew Forrest and PhIRDA Executive President Mr. Song Ruilin
Bringing International Partners Together
In recent months, the Asian Fund for Cancer Research (AFCR) has established relationships with two fellow Pacific Rim institutions: the China…